Lipidomics-based exploration of risk factors for cardiovascular complications in maintenance dialysis patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500110825

Enrollment

Unknown

Registered

2025-10-21

Start date

2025-10-30

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure, peripheral vascular disease, stroke, hemodialysis

Interventions

Observational group:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.More than 18y; 2.More than 1 month in dialysis; 3.No active infections, malignant tumors, or acute cardiovascular events within one month prior to enrollment.

Exclusion criteria

Exclusion criteria: 1.Expected survival period less than 1 year; 2.Received a blood transfusion or immunosuppressive therapy within 3 months prior to enrollment; 3.History of Inherited Metabolic Disorders; 4.Patients receiving combined hemodialysis and peritoneal dialysis therapy;

Design outcomes

Primary

Measure	Time frame
Cardiovascular disease mortality or new cardiovascular events;	—

Secondary

Measure	Time frame
All-cause mortality;Vascular calcification worsens;Arterial plaque worsens;	—

Countries

China

Contacts

Public ContactLin Pan

Shanghai Geriatric Medical Center

lin.pan@zsgmc.sh.cn+86 21 5991002

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026